DC Chemicals

All products / DC9862

Niraparib(MK4827) hydrochloride
CAT. NO. DC9862

Niraparib(MK4827) hydrochloride

Pack sizes and prices

Pack sizePrice
100 mg$500 USDRequest a quote →
250 mg$900 USDRequest a quote →
1 g$1,900 USDRequest a quote →

In stock. Contact our team for lead time, shipping and final quotation.

Product overview

Niraparib hydrochloride (MK-4827 hydrochloride) is an excellent PARP1 and PARP2 inhibitor with IC50 of 3.8 and 2.1 nM, respectively.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC9862
Product nameNiraparib(MK4827) hydrochloride
CAS1038915-64-8
Molecular formulaC19H21ClN4O
Molecular weight356.854
Purity99%
SMILESNC(C1=CC=CC2=CN(C3=CC=C([C@H]4CNCCC4)C=C3)N=C21)=O.Cl

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — Niraparib(MK4827) hydrochloride (DC9862)

Source references

[1]. Jones P, et al. Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors. J Med Chem. 2009 Nov 26;52(22):7170-85. [2]. Bridges KA, et al. Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells. Oncotarget. 2014 Jul 15;5(13):5076-86. [3]. Wang L, et al. MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation. Invest New Drugs. 2012 Dec;30(6):2113-20.

Related research products